Lamm, Wolfgang, Hannes Kaufmann, Markus Raderer, Martha Hoffmann, Andreas Chott, Christoph Zielinski, and Johannes Drach. 2011. “Bortezomib Combined With Rituximab and Dexamethasone Is an Active Regimen for Patients With Relapsed and Chemotherapy-Refractory Mantle Cell Lymphoma”. Haematologica 96 (7). Pavia, Italy, 1008-14. https://doi.org/10.3324/haematol.2011.041392.